Why VBI Vaccines Stock Is Skyrocketing Today
Shares of VBI Vaccines (NASDAQ: VBIV) were up 45% as of 11:18 a.m. EDT on Thursday after rising as much as 62% earlier in the session. The huge jump came after Raymond James analyst Steven Seedhouse upgraded the stock from outperform to strong buy and raised his price target from $8 to $9.
Analyst upgrades usually help stocks -- and especially small biotech stocks. But the massive gain for VBI Vaccines is certainly out of the ordinary.
Image source: Getty Images
Source Fool.com
